U.S., March 11 -- ClinicalTrials.gov registry received information related to the study (NCT06867874) titled 'Syncytiotrophoblast-derived Extracellular Vesicles in Placenta Previa and Accreta Spectrum' on July 10, 2023.
Brief Summary: The main goal of this case-control study is to quantify the levels of circulating syncytiotrophoblast-derived extracellular vesicles (STBEVs) in maternal blood in a population of women with placenta previa and placenta accreta spectrum.
Study Start Date: July 10, 2023
Study Type: INTERVENTIONAL
Condition:
Placenta Previa
Placenta Accreta Spectrum
Intervention:
PROCEDURE: Blood sample
Blood sample
Recruitment Status: RECRUITING
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Disc...